Related Experiment Video
Updated: May 13, 2026

06:37
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
Published on: February 3, 2017
Parthenogenetic stem cells for tissue-engineered heart repair.
Michael Didié1, Peter Christalla, Michael Rubart
1Institute of Pharmacology, University Medical Center Göttingen, Göttingen, Germany.
The Journal of Clinical Investigation
|February 26, 2013
Summary
Parthenogenetic stem cells (PSCs) show pluripotency and can be directed to form cardiomyocytes for tissue-engineered heart repair. These cells offer potential for allogeneic therapies due to their unique genetic properties.
Area of Science:
- Developmental Biology
- Stem Cell Biology
- Regenerative Medicine
- Cardiovascular Research
Background:
- Uniparental parthenotes, a byproduct of in vitro fertilization, exhibit developmental defects, particularly in cardiogenesis.
- Despite developmental issues, pluripotent stem cells can be isolated from parthenogenetic blastocysts.
- Parthenogenetic stem cells (PSCs) possess unique genetic and epigenetic characteristics, including MHC haploidentity.
Purpose of the Study:
- To investigate the potential of nonembryonic parthenogenetic stem cells (PSCs) for cardiac lineage differentiation.
- To evaluate PSCs as a source for tissue-engineered heart repair.
- To compare PSCs with embryonic stem cells (ESCs) regarding pluripotency and cardiogenicity.
Main Methods:
- Comparison of fundamental properties between murine PSCs and ESCs.
- Assessment of PSC acceptance in MHC-matched allotransplantation.
- Directed differentiation of PSCs and ESCs into cardiomyocytes, utilizing cardiomyocyte-restricted GFP for cell sorting and analysis.
- Engineering of force-generating myocardium from enriched cardiomyocytes.
Main Results:
- PSCs exhibit fundamental properties similar to ESCs, with notable genetic and epigenetic differences.
- PSCs were accepted in MHC-matched allotransplantation, highlighting their potential for allogeneic therapies.
- Cardiomyocyte derivation from PSCs was as effective as from ESCs, with advanced structural and functional maturation observed.
- PSC-derived cardiomyocytes integrated electrically into recipient myocardium and improved regional function post-myocardial infarction.
Conclusions:
- Parthenogenetic stem cells (PSCs) demonstrate pluripotency and unrestricted cardiogenicity.
- PSCs represent a promising and unique cell source for tissue-engineered heart repair.
- The MHC haploidentity of PSCs is advantageous for allogeneic cell-based therapeutic strategies.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Embryonic Stem Cells
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

